when was tirzepatide approved FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Lilly's Zepbound (aka tirzepatide) Lands

CHRIS MASTERJOHN: Im not sure

FDA Advisory Committee Recommends Adding BPC-157 to Compounding List A closely watched FDA advisory committee has voted to recommend adding BPC-157 to the list of bulk drug substances that may be used by traditional compounding pharmacies, marking a potentially significant development for providers who have followed growing interest in peptide therapies

The researchers also boiled down their findings in a way that could be useful for busy doctors and families trying to decide what to do

BioPharma Dive: FDA Peptides RFK Advisory Committee Restrictions RAPS: FDA Considers Adding a Dozen Peptides to Bulk Drug List Ars Technica: RFK Jr

Legitimate programs name the pharmacy because the patient needs to know who is filling the prescription